|
|
0-24 Hour |
0-1 Year |
1-5 Year |
0-5 Year |
5-10 Year |
0-10 Year |
|
S% (p) |
aHR (p) |
S% (p) |
aHR
(p) |
S% (p) |
aHR
(p) |
S% (p) |
aHR (p) |
S% (p) |
aHR
(p) |
S% (p) |
aHR
(p) |
Donor/FCXM |
|
|
|
|
|
|
|
|
|
|
|
|
LD T-B- |
99.4 |
|
95.8 |
|
86.1 |
|
82.5 |
|
69.5 |
|
57.4 |
|
vs. LD T+ |
98.6 (0.06) |
1.5 (0.22) |
89.4*
(<.0001) |
1.8* (<.0001) |
80.9* (0.01) |
1.1 (0.50) |
72.3*
(<.0001) |
1.4* (0.0002) |
65.7 (0.32) |
1.0 (0.98) |
47.5* (<.0001) |
1.3* (0.0005) |
vs. LD T-B+ |
99.0 (0.05) |
1.1 (0.72) |
93.9* (0.002) |
1.1 (0.50) |
80.8* (<.0001) |
1.3* (0.005) |
75.9* (<.0001) |
1.2* (0.007) |
70.8 (0.72) |
1.0 (0.88) |
53.7* (<.0001) |
1.2* (0.008) |
DD T-B- |
99.1 |
|
91.4 |
|
77.5 |
|
70.8 |
|
58.6 |
|
41.5 |
|
vs. DD T+ |
97.8* (0.001) |
1.6 (0.09) |
86.5* (<.0001) |
1.4* (0.003) |
75.6 (0.36) |
1.1 (0.56) |
65.4* (0.0003) |
1.2* (0.01) |
54.0 (0.92) |
1.0 (0.94) |
35.3* (0.001) |
1.2* (0.02) |
vs. DD T-B+ |
98.5* (0.02) |
1.2 (0.32) |
90.4 (0.13) |
1.0 (0.60) |
73.9* (0.01) |
1.2* (0.02) |
66.8* (0.002) |
1.1 (0.18) |
54.3 (0.08) |
1.2 (0.12) |
36.2* (0.0004) |
1.1 (0.08) |
LD T-B- CDCXM/FCXM- |
99.5 |
|
97.0 |
|
91.0 |
|
88.2 |
|
81.3 |
|
71.8 |
|
vs. LD T+ CDCXM/FCXM+ |
95.9* (0.001) |
1.9 (0.39) |
85.5* (<.0001) |
2.4* (0.03) |
96.2 (0.58) |
0.3 (0.18) |
82.2* (0.006) |
1.3 (0.49) |
75.0 (0.38) |
0.9 (0.94) |
61.7* (0.004) |
1.3 (0.48) |
vs. LD T-B+ CDCXM/FCXM+ |
99.1 (0.60) |
0.6 (0.56) |
91.7* (0.006) |
1.0 (0.99) |
89.0 (0.41) |
0.6 (0.30) |
81.5* (0.01) |
0.8 (0.43) |
NA |
NA |
NA |
NA |
DD T-B- CDCXM/FCXM- |
99.0 |
|
93.8 |
|
84.9 |
|
79.7 |
|
77.0 |
|
61.3 |
|
vs. DD T+ CDCXM/FCXM+ |
95.7* (0.03) |
2.8 (0.16) |
89.1 (0.16) |
1.1 (0.83) |
88.5 (0.55) |
0.5 (0.27) |
78.8 (0.60) |
0.8 (0.53) |
NA |
1.7 (0.47) |
NA |
NA |
vs. DD T-B+ CDCXM/FCXM+ |
99.0 (0.92) |
0.3 (0.24) |
86.6* (0.003) |
1.1 (0.73) |
87.4 (0.91) |
0.7 (0.31) |
75.7 (0.07) |
0.9 (0.56) |
84.4 (0.59) |
0.5 (0.24) |
63.9 (0.18) |
0.8 (0.26) |
* P<0.05, S(%), survival fraction from start to end of the interval.
Produced from OPTN Standard Transplant Analysis and Research Files for transplants performed in 1995–2009 [48], Xiao H and Lentine KL, 2011. The sample with
FCXM results comprised 23331 LD and 29819 DD recipients. The sample with CDCXM and FCXM results comprised 6736 LD and 6210 DD recipients. |
